Elsevier

Epilepsy & Behavior

Volume 73, August 2017, Pages 214-235
Epilepsy & Behavior

Review
The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy

https://doi.org/10.1016/j.yebeh.2017.05.040Get rights and content

Highlights

  • The relevance of individual genetic background and its role in models of epilepsy is discussed.

  • Strain background of mice and rats critically affects the expression of seizures.

  • This is true for both outbred and inbred strains of mice and rats.

  • In addition, environmental and epigenetic factors can affect seizure expression.

  • Thus, researchers should know the exact stock or strain of rodents they are utilizing.

Abstract

It is becoming increasingly clear that the genetic background of mice and rats, even in inbred strains, can have a profound influence on measures of seizure susceptibility and epilepsy. These differences can be capitalized upon through genetic mapping studies to reveal genes important for seizures and epilepsy. However, strain background and particularly mixed genetic backgrounds of transgenic animals need careful consideration in both the selection of strains and in the interpretation of results and conclusions. For instance, mice with targeted deletions of genes involved in epilepsy can have profoundly disparate phenotypes depending on the background strain. In this review, we discuss findings related to how this genetic heterogeneity has and can be utilized in the epilepsy field to reveal novel insights into seizures and epilepsy. Moreover, we discuss how caution is needed in regards to rodent strain or even animal vendor choice, and how this can significantly influence seizure and epilepsy parameters in unexpected ways. This is particularly critical in decisions regarding the strain of choice used in generating mice with targeted deletions of genes. Finally, we discuss the role of environment (at vendor and/or laboratory) and epigenetic factors for inter- and intrastrain differences and how such differences can affect the expression of seizures and the animals' performance in behavioral tests that often accompany acute and chronic seizure testing.

Introduction

Similar to humans, genetic background plays an important role in modulating both seizure susceptibility and its neuropathological consequences in rodent models of seizures or epilepsy, a factor which has received inadequate consideration in prior studies [1]. Outbred strains of mice (e.g., Swiss, NMRI or CD-1) or rats (e.g., Wistar or Sprague–Dawley (SD)) have been widely used in models of seizures or epilepsy, but such outbred strains can increase seizure variability with a high intrastrain phenotypic variation due to genetic heterogeneity [2], [3]. Genetic divergence between outbred subpopulations may arise from a number of mechanisms, including natural selection, mutation, unconscious experimenter selection, and genetic drift [2], [3]. Such intrastrain differences may be an important reason for discrepancies between studies from different laboratories using outbred strains. However, outbred strains of rodents can have important contributions to experimental design, since in many ways they can model the genetic diversity observed in the human population. But the genetic variance imparted by the use of outbred strains also needs to be factored into the experimental interpretations, particularly as it may relate to the understanding of single gene effects being studied (i.e., targeted deletions of genes). Furthermore, apart from genetics, intrastrain and interstrain differences in models of seizures or epilepsy can also be due to the environmental conditions under which the animals are bred and maintained [4].

It is generally assumed that using inbred strains of mice or rats minimizes the effect of intrastrain differences because of genetic homogeneity within inbred strains. However, the inbreeding that makes an inbred strain so useful can also result in genetic divergence between differing substrains of the same inbred strain. This genetic divergence is often unaccounted for in experiments, but may be a confounding factor when comparing studies that have utilized different inbred substrains [1]. Inbred mouse strains may contain hidden or “quiet” mutations, that have no discernable effect, but which may be uncovered during behavioral phenotyping [5], [6]. Inbred strains are also subject to new mutations and to genetic drift during breeding [5]. Careful attention is needed in rodent colony management to prevent or limit genetic drift by reintroducing the parental strain systematically into breeding programs. Furthermore, variation of the environmental conditions under which the animals are bred and reared at a specific vendor may have marked effects on animal behavior once the rodents are used for experiments, not to mention variabilities from University animal facility to animal facility. In addition, genetically similar mice from different commercial vendors may exhibit differences in their gut microbiota composition, which can exert profound variation in animal models [7], [8].

When discussing strain effects on expression of seizures and epilepsy, it is important to consider the commonly misapplied distinction of wild-type rodents [9]. Multiple studies have demonstrated that some inbred strains of so-called wild-type mice, even if they never show spontaneous seizures, can be much more easily induced to have seizures than other wild-type strains. Clearly, mice are only wild-type with respect to a specific genetic locus and according to a specific user-defined assay for the structure or function of that locus in a controlled laboratory environment [9]. Every “wild-type” mouse carries multiple genetic differences (mutations or polymorphisms) that distinguish it from mice of other strains, although only some of these differences produce phenotypes that are obvious to a scientist, and many fewer that are relevant to phenotypes related to seizures and epilepsy. Nonetheless, a large body of evidence has accrued to document the strong influence of genetic variation on susceptibility to seizures or epilepsy, especially in rodent models.

In this review, it is not possible to discuss all the innumerous studies that have demonstrated inter- and intrastrain strain effects on expression of seizures and epilepsy in laboratory mice and rats. Rather, we will illustrate the impact of such strain effects by reviewing a series of experiments that were performed by our groups in the last ~ 25 years in a variety of models of seizures and epilepsy. Furthermore, some important studies from other groups will be highlighted. This review will not deal with rodent models of genetic epilepsies, such as spontaneously occurring mutants or genetically engineered rodents (including knockout and transgenic strains or lines) that are widely used as models of epilepsy. Our aim is to emphasize that even in the absence of engineered mutations, different inbred strains, and even substrains of the same inbred strain or sublines of the same substrain, can vary drastically in their susceptibility to induction of seizures or epilepsy. However, these genetic differences present opportunities to identify biological factors (i.e., genes) that are relevant to elucidating mechanisms of seizures and epilepsy. Thus, the use of different strain backgrounds, when studying epilepsy mutations, enhances the modeling of epilepsy as a complex genetic disease [10] and facilitates insight into the pathophysiology of epilepsy and for potential treatments. Another important issue that we will discuss is that, in addition to genetic inter- and intrastrain differences in rodents, differences in housing and handling of the animals, both at the vendor and in the laboratory, may have a marked impact on the expression of seizures and associated behavioral alterations. Importantly, some of these factors may have effects that are strain-specific. Lastly, we will briefly discuss age and sex differences in the expression of seizures and epilepsy in rodents and how this may affect inter- and intrastrain differences, whereas we will not discuss species (mouse vs. rat) differences that are of documented importance when interpreting data from rodent models of seizures or epilepsy.

Section snippets

Intrastrain differences in mice and rats

As described in the introduction, genetic intrastrain differences can occur in both outbred and inbred strains of mice and rats. Furthermore, epigenetic differences may occur in response to the environment under which the animals are born and raised (see Section 6).

For generating seizure or epilepsy models in rats, outbred strains such as Wistar or SD are often used. Outbred rat strains are known to be genetically heterogeneous populations with a high intrastrain phenotypic variation [2], [3],

Interstrain differences in the expression of seizures and epilepsy in mice

Inbred strains of rodents have been used for many decades in biomedical research as a means to reduce experimental variability and enhance scientific reproducibility, particularly with regards to studies that are conducted by different research teams in different laboratories. With the creation of the DBA/1 and DBA/2 inbred mouse strains in the early 1900s, and the generation of additional families of inbred strains, including C3H, CBA and B6, several decades later, the biomedical research

Interstrain differences in the expression of seizures and epilepsy in rats

Similar to mice, differing rat strains have a marked effect on expression of seizures and epilepsy in a variety of models [1], [10], [50]. In most studies on seizures and epilepsy in rats, outbred strains such as Wistar or SD are used, which increases variability of the data because of the intrastrain genetic differences in such outbred animals (see Section 2).

Dissection of genes that may underlie differences in expression of seizures or epilepsy

Classical, forward genetic mapping studies of seizures and epilepsy-related phenotypes have taken advantage of a number of the strain differences discussed in Section 3 and have led to the identification of a diverse set of genes that may be useful to consider in regard to elucidating biological mechanisms of seizures and epilepsy and developing new therapies for epilepsy patients. In general, epilepsy-related genes identified using inbred mice are difficult to validate because, like other

Role of environment (at vendor and/or laboratory) and epigenetic factors for inter- and intra-strain differences

In addition to genetic differences in mice and rat strains, various other confounding variables can affect the expression of seizures or epilepsy (Fig. 4). These factors can lead to troublesome variability in rodent studies, and should be carefully considered in designing and interpreting in vivo experiments [6], [182], [183], [184].

A very impressive example of the magnitude of the problem was reported by Crabbe et al. in 1999 [185]. In this study, possible confounding influences of the

Role of sex for inter- and intrastrain differences

Sex differences in seizure susceptibility in rodent models have been described in many studies [195], [196], [197], [198]. Although robust effects of sex on seizures have been reported, and numerous effects of gonadal steroids on seizure thresholds have been shown throughout the rodent brain, results have differed greatly depending on the method used to induce seizures, how seizures were measured (seizure threshold, latency to seizure onset, seizure severity or duration), species, age, and time

Inter- and intra-strain differences affect performance in the behavioral tests that often accompany acute and chronic seizure testing

In addition to inter- and intra-strain effects on expression of seizures or epilepsy, inter- and intra-strain differences in rats and mice may also affect performance of animals in the behavioral tests that often accompany seizure testing, such as tests for anxiety-related behaviors, depression-related behaviors, and cognition and memory. Inter-individual differences in behavior in a given strain may also affect subsequent induction of epilepsy, thus paralleling the association between

Conclusions

While we were not able to discuss all of the studies related to genetic heterogeneity among rodent strains in mediating seizures and epilepsy due to space limitations, it has become clear that the background strain of the rodent utilized as a model, and even the vendor and housing location in the vendor's barriers, can have a profound effect on seizures. This work highlights the importance of paying particular attention to the strain being utilized and the vendor source, since this may have

Recommendations

Rodent models of seizures and epilepsy should be optimized to address specific research questions. Since, as reviewed in this paper, both genetics and environment can each have a large influence on rodent responses in seizure and epilepsy models, experiments may be designed to study either genetic or environmental influences separately, or to study their interaction. In studies focused on elucidating the impact of factors in the environment, it is imperative that rodents are of the same genetic

Conflict of interest

The authors declare no conflict of interest.

Acknowledgements

This work was supported, in part, by an NIH/NINDS R01NS064283 grant to RJF. WL's studies have been supported by grants from the German Research Foundation (Bonn, Germany) and the European Union's Seventh Framework Programme (FP7) under grant agreements 201380 (EURIPIDES) and 602102 (EPITARGET).

References (218)

  • G. Curia et al.

    The pilocarpine model of temporal lobe epilepsy

    J Neurosci Methods

    (2008)
  • K. Borges et al.

    Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model

    Exp Neurol

    (2003)
  • M. Bankstahl et al.

    Generation and characterization of pilocarpine-sensitive C57BL/6 mice as a model of temporal lobe epilepsy

    Behav Brain Res

    (2012)
  • A.E. Kosobud et al.

    Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs

    Brain Res

    (1990)
  • C. Brandt et al.

    The pilocarpine model of temporal lobe epilepsy: marked intrastrain differences in female Sprague–Dawley rats and the effect of estrous cycle

    Epilepsy Behav

    (2016)
  • C. Brandt et al.

    Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats

    Epilepsy Res

    (2003)
  • S. Honndorf et al.

    Female Wistar rats obtained from different breeders vary in anxiety-like behavior and epileptogenesis

    Epilepsy Res

    (2011)
  • R.J. Racine et al.

    Development of kindling-prone and kindling-resistant rats: selective breeding and electrophysiological studies

    Epilepsy Res

    (1999)
  • P. Sharma et al.

    Neuroanatomical differences in FAST and SLOW rat strains with differential vulnerability to kindling and behavioral comorbidities

    Epilepsy Behav

    (2016)
  • W. Löscher

    Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs

    Seizure

    (2011)
  • M. Bankstahl et al.

    Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy

    Exp Neurol

    (2012)
  • W. Löscher

    Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies

    Epilepsy Res

    (2016)
  • S. Bröer et al.

    Brain inflammation, neurodegeneration and seizure development following picornavirus infection markedly differ among virus and mouse strains and substrains

    Exp Neurol

    (2016)
  • C.T. Wotjak

    C57BLack/BOX? The importance of exact mouse strain nomenclature

    Trends Genet

    (2003)
  • T.N. Ferraro

    Sixty years in the making: a polygenic mouse model of seizure susceptibility

  • T.N. Ferraro et al.

    Genetic influences on electrical seizure threshold

    Brain Res

    (1998)
  • W.N. Frankel et al.

    Electroconvulsive thresholds of inbred mouse strains

    Genomics

    (2001)
  • C.M. Dube et al.

    Febrile seizures: mechanisms and relationship to epilepsy

    Brain Dev

    (2009)
  • A.E. Kosobud et al.

    Neural sensitivity to pentylenetetrazol convulsions in inbred and selectively bred mice

    Brain Res

    (1992)
  • R.D. Schwartz et al.

    Differential seizure sensitivities to picrotoxinin in two inbred strains of mice (DBA/2J and BALB/c ByJ): parallel changes in GABA receptor-mediated chloride flux and receptor binding

    Brain Res

    (1989)
  • R.K. Freund et al.

    Differential sensitivity to bicuculline in three inbred mouse strains

    Brain Res Bull

    (1987)
  • R.J. Marley et al.

    Genetic influences on GABA-related seizures

    Pharmacol Biochem Behav

    (1986)
  • T.W. Seale et al.

    Coincidence of seizure susceptibility to caffeine and to the benzodiazepine inverse agonist, DMCM, in SWR and CBA inbred mice

    Pharmacol Biochem Behav

    (1987)
  • C. Desforges et al.

    Beta-Carboline-induced seizures in mice: genetic analysis

    Pharmacol Biochem Behav

    (1989)
  • K. Bernard-Helary et al.

    In vivo and in vitro glycogenic effects of methionine sulfoximine are different in two inbred strains of mice

    Brain Res

    (2002)
  • J.G. Clement et al.

    Differences in the toxicity of soman in various strains of mice

    Fundam Appl Toxicol

    (1981)
  • M.R. Winawer et al.

    Acute and chronic responses to the convulsant pilocarpine in DBA/2J and A/J mice

    Neuroscience

    (2007)
  • R.J. Marley et al.

    Genetic factors influence changes in sensitivity to the convulsant properties of cocaine following chronic treatment

    Brain Res

    (1991)
  • L.L. Miner et al.

    Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors

    Pharmacol Biochem Behav

    (1989)
  • P.E. Schauwecker

    Strain differences in seizure-induced cell death following pilocarpine-induced status epilepticus

    Neurobiol Dis

    (2012)
  • S.E. File

    Strain differences in mice in the development of tolerance to the anti-pentylenetetrazole effects of diazepam

    Neurosci Lett

    (1983)
  • J.M. Wehner et al.

    Genetic differences in the effects of delta-aminolevulinic acid on seizure latency in mice

    Exp Neurol

    (1986)
  • M.R. Johnson et al.

    Newly diagnosed epilepsy and pharmacogenomics research: a step in the right direction?

    Epilepsy Behav

    (2011)
  • V. Riban et al.

    Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy

    Neuroscience

    (2002)
  • M.F. Festing

    Genetic variation in outbred rats and mice and its implications for toxicological screening

    J Exp Anim Sci

    (1993)
  • M.F. Festing

    Inbred strains should replace outbred stocks in toxicology, safety testing, and drug development

    Toxicol Pathol

    (2010)
  • P.W. Burnet

    Gut bacteria and brain function: the challenges of a growing field

    Proc Natl Acad Sci U S A

    (2012)
  • N.F. Villarino et al.

    Composition of the gut microbiota modulates the severity of malaria

    Proc Natl Acad Sci U S A

    (2016)
  • S. Kacew et al.

    Role of rat strain in the differential sensitivity to pharmaceutical agents and naturally occurring substances

    J Toxicol Environ Health

    (1996)
  • D.M. Yilmazer-Hanke

    Morphological correlates of emotional and cognitive behaviour: insights from studies on inbred and outbred rodent strains and their crosses

    Behav Pharmacol

    (2008)
  • Cited by (51)

    • Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs

      2022, Experimental Neurology
      Citation Excerpt :

      Although the most essential element of this model, microinjection of KA into the BLA, has been used by a number of laboratories for a variety of purposes, several methodological variations have been reported. Additionally, different substrains of C57BL/6 mice have been used in these reports which further contributes to inter-laboratory variability (Goldstein and Wagers, 2018; Kang et al., 2019; Löscher et al., 2017; Mekada and Yoshiki, 2021). In evaluating the effects of some of these variables, our purpose was not to resolve any disparity between our data and the data reported by others; instead, our goal was to develop a version of this model that maintained most of the essential experimental elements of these models described elsewhere, while optimizing quantitative endpoints suitable for future studies on the pharmacology of refractory seizures.

    • The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model

      2022, Neuropharmacology
      Citation Excerpt :

      However, in apparent contrast to some previous studies (Rostock et al., 1996; Large et al., 2012), retigabine was ineffective against audiogenic seizures in DBA/2 mice and 6-Hz induced focal seizures in NMRI mice. Such differences across different laboratories are most likely a result of genetic and epigenetic differences in rodent strains and substrains as well as technical factors, which have been described to affect drug testing in seizure models (Löscher et al., 2017). This demonstrates the importance of comparing the antiseizure efficacies of novel compounds such as GRT-X with those of clinically approved ASDs such as retigabine in the same laboratory, using the same strain or substrain of mice and rats.

    • SGK1.1 limits brain damage after status epilepticus through M current-dependent and independent mechanisms

      2021, Neurobiology of Disease
      Citation Excerpt :

      Importantly, the protective effect mediated by SGK1.1 is robust and independent of the genetic background. It is maintained in FVB/NJ mice, a strain associated to higher levels of neurodegeneration than C57BL/6 J (Loscher et al., 2017). Neuroprotection is due to SGK1.1 activation, since acute kinase inhibition with the specific inhibitor EMD638683 lead to equal levels of neuronal death in both genotypes.

    View all citing articles on Scopus
    View full text